A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.
Clinical trial NCT05858788 · COMPLETED
Trial details
- NCT number
- NCT05858788
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2023-07-17
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.